Zhang Bin, Spreafico Marta, Zheng Chunlei, Yang Angela, Platzer Petra, Callaghan Michael U, Avci Zekai, Ozbek Namik, Mahlangu Johnny, Haw Tabitha, Kaufman Randal J, Marchant Kandice, Tuddenham Edward G D, Seligsohn Uri, Peyvandi Flora, Ginsburg David
Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.
Blood. 2008 Jun 15;111(12):5592-600. doi: 10.1182/blood-2007-10-113951. Epub 2008 Apr 7.
Combined deficiency of factor V and factor VIII (F5F8D) is caused by mutations in one of 2 genes, either LMAN1 or MCFD2. Here we report the identification of mutations for 11 additional F5F8D families, including 4 novel mutations, 2 in MCFD2 and 2 in LMAN1. We show that a novel MCFD2 missense mutation identified here (D81Y) and 2 previously reported mutations (D89A and D122V) abolish MCFD2 binding to LMAN1. Measurement of platelet factor V (FV) levels in 7 F5F8D patients (4 with LMAN1 and 3 with MCFD2 mutations) demonstrated similar reductions to those observed for plasma FV. Combining the current data together with all previous published reports, we performed a genotype-phenotype analysis comparing patients with MCFD2 mutations with those with LMAN1 mutations. A previously unappreciated difference is observed between these 2 classes of patients in the distribution of plasma levels for FV and factor VIII (FVIII). Although there is considerable overlap, the mean levels of plasma FV and FVIII in patients with MCFD2 mutations are significantly lower than the corresponding levels in patients with LMAN1 mutations. No differences in distribution of factor levels are observed by sex. These data suggest that MCFD2 may play a primary role in the export of FV and FVIII from the ER, with the impact of LMAN1 mediated indirectly through its interaction with MCFD2.
凝血因子V和凝血因子VIII联合缺乏症(F5F8D)由LMAN1或MCFD2这两个基因之一的突变引起。在此,我们报告了另外11个F5F8D家系的突变鉴定结果,包括4个新突变,其中2个在MCFD2中,2个在LMAN1中。我们发现,此处鉴定出的一个新的MCFD2错义突变(D81Y)以及之前报道的2个突变(D89A和D122V)消除了MCFD2与LMAN1的结合。对7例F5F8D患者(4例LMAN1突变患者和3例MCFD2突变患者)的血小板凝血因子V(FV)水平进行测量,结果显示其降低程度与血浆FV相似。将当前数据与之前所有已发表的报告相结合,我们对MCFD2突变患者和LMAN1突变患者进行了基因型-表型分析。在这两类患者的FV和凝血因子VIII(FVIII)血浆水平分布上观察到了一个之前未被认识到的差异。尽管存在相当大的重叠,但MCFD2突变患者的血浆FV和FVIII平均水平显著低于LMAN1突变患者的相应水平。未观察到因子水平分布在性别上的差异。这些数据表明,MCFD2可能在FV和FVIII从内质网的输出中起主要作用,而LMAN1的影响是通过其与MCFD2的相互作用间接介导的。